{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-243709","form_type":"8-K","ticker":"CTMX","cik":"0001501989","company_name":"CytomX Therapeutics, Inc.","filed_at":"2022-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.950262+00:00","generated_at":"2026-06-23T09:59:43.829996+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CytomX enters consulting agreements with former COO and CFO","bullets":["Amy Peterson, former President and COO, to provide consulting at $500/hour effective Sept 13, 2022.","Carlos Campoy, SVP and CFO, to provide consulting at $500/hour effective Oct 1, 2022.","Both agreements have one-year terms with 30-day termination notice.","Peterson's services include clinical development; Campoy provides biotech and financial advice."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-243709","json":"https://secwatch.observer/filing/0001193125-22-243709.json","markdown":"https://secwatch.observer/filing/0001193125-22-243709.md","text":"https://secwatch.observer/filing/0001193125-22-243709.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501989/000119312522243709/0001193125-22-243709-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501989/000119312522243709/d335361d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T09:59:43.829996+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}